| abstract |
A pharmaceutical composition comprising at least one C1ORF32 ectodomain polypeptide selected from the group consisting of: i. a C1ORF32 ectodomain polypeptide consisting of the amino acid sequence in SEQ ID NO: 299; ii. a C1ORF32 ectodomain polypeptide consisting of the amino acid sequence in SEQ ID NO: 147; iii. a C1ORF32 ectodomain polypeptide consisting of the amino acid sequence in SEQ ID NO: 148; iv. a C1ORF32 ectodomain variant polypeptide having a sequence identity of at least 95% with the amino acid sequences in SEQ ID NO: 299, SEQ ID NO: 147 or SEQ ID NO: 148; and a pharmaceutically acceptable diluent or carrier. |